Pankowicz, F. P., Barzi, M., Legras, X., Hubert, L., Mi, T., Tomolonis, J. A., . . . Bissig, K. (2016). Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia. Nature Portfolio.
Cita Chicago Style (17a ed.)Pankowicz, Francis P., et al. Reprogramming Metabolic Pathways in Vivo with CRISPR/Cas9 Genome Editing to Treat Hereditary Tyrosinaemia. Nature Portfolio, 2016.
Cita MLA (8a ed.)Pankowicz, Francis P., et al. Reprogramming Metabolic Pathways in Vivo with CRISPR/Cas9 Genome Editing to Treat Hereditary Tyrosinaemia. Nature Portfolio, 2016.
Precaución: Estas citas no son 100% exactas.